Study reveals safe mannitol dosing for brain injury patients
NCT ID NCT06846307
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how different amounts of mannitol, a medicine used to reduce brain swelling, change blood osmolarity (a measure of blood thickness) in people with traumatic brain injury. Researchers observed 64 patients aged 18-40 with mild to moderate head injuries. The goal was to find safer ways to use mannitol by understanding its effect on the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dr. Kariadi Central General Hospital
Semarang, Central Java, Indonesia